Cargando…
SAHA is neuroprotective in in vitro and in situ models of retinitis pigmentosa
Purpose: Recent reports linking HDAC6 to mitochondrial turnover and neurodegeneration led us to hypothesize that an inhibitor such as Vorinostat (suberoylanilide hydroxamic acid, SAHA) may reduce mitochondrial damage found in retinitis pigmentosa (RP), a progressive neurodegenerative disease of the...
Autores principales: | Perron, Nathan R., Nasarre, Cécile, Bandyopadhyay, Mausumi, Beeson, Craig C., Rohrer, Baerbel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Molecular Vision
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8056468/ https://www.ncbi.nlm.nih.gov/pubmed/33907370 |
Ejemplares similares
-
Large-scale phenotypic drug screen identifies neuroprotectants in zebrafish and mouse models of retinitis pigmentosa
por: Zhang, Liyun, et al.
Publicado: (2021) -
Identification of candidate genes for human retinal degeneration loci using differentially expressed genes from mouse photoreceptor dystrophy models
por: Demos, Christina, et al.
Publicado: (2008) -
Therapeutic Challenges to Retinitis Pigmentosa: From Neuroprotection to Gene Therapy
por: Sahni, Jayashree N, et al.
Publicado: (2011) -
Transcriptional Profiling Identifies Upregulation of Neuroprotective Pathways in Retinitis Pigmentosa
por: Bielmeier, Christina B., et al.
Publicado: (2021) -
Investigations Into Bioenergetic Neuroprotection of Cone Photoreceptors: Relevance to Retinitis Pigmentosa
por: Narayan, Daniel S., et al.
Publicado: (2019)